Cidara Therapeutics Inc (NASDAQ:CDTX)

1.26
BATS BZX Real-Time Price
As of 11:49am ET
 +0.055 / +4.56%
Today’s Change
0.40
Today|||52-Week Range
2.10
+66.60%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Cidara Therapeutics Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +296.83% increase from the last price of 1.26.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Cidara Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.04
Sales
$18.7M
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 80.70%
 
 
 
 
 
 
Growthannually 10.85%
 
 
 
 
 
 

Sales

Growthquarterly 82.83%
 
 
 
 
 
 
Growthannually -20.75%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.